4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000117
Director sold 467 shares at $402.95 ($188,178)
- Director acquired 1,001 shares (grant or award)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Bhatia Sangeeta N. · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-01 | Grant or award : show line 1 in the form 10b5-1 | +1,001 | 4,902 | D | ||
| 2024-05-02 | Sale : show line 2 in the form 10b5-1 | −467 | $402.95 | $188,178 | 4,435 | D |
| Open-market sales · 467 sh · avg $402.95 · $188,178 | ||||||
Loading xslF345X05/wk-form4_1714766716.xml…